11:35 PM EDT, 08/03/2026 (MT Newswires) -- Fresenius Medical Care (FME.F) on Monday confirmed its financial outlook for 2026. Revenue growth is still expected to be broadly flat compared with 2025, and operating income at a consistent level, ranging between positive and negative mid-single-digit percent growth rate from a year ago. The dialysis services and products company's revenue was 19.63 billion euros in 2025, with operating income of 2.21 billion euros.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.